Journals
Publish with us
Publishing partnerships
About us
Blog
International Scholarly Research Notices
Table of Contents
International Scholarly Research Notices
/
2012
/
Article
/
Tab 3
/
Clinical Study
Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer
Table 3
PSA response.
𝑁
Median
Min
Max
PSA doubling time (months) pretreatment
15
4.7
0.8
9.9
PSA doubling time (moths) on therapy
15
6.5
0.8
29.4